PLM-101 is a novel and potent FLT3/RET inhibitor with less adverse effects in the treatment of acute myeloid leukemia
2023 · Biomedicine & Pharmacotherapy · 7 citations
https://doi.org/10.1016/j.biopha.2023.115066
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
29
Citations
2
h-index
1
i10-index
Su-Jin Oh is an academic researcher from Sejong University. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Acute Myeloid Leukemia Research & Lipid Membrane Structure and Behavior. The author has an h-index of 2, co-authored 4 publications.
Click to start Chat